Table 3.
Parameter | WT male + Ang II (n=9) |
PT-Agtr1a−/− male + Ang II (n=9) |
WT female + Ang II (n=8) |
PT-Agtr1a−/−female + Ang II (n=10) |
---|---|---|---|---|
Body wt., g | 23.0 ± 0.5 | 26.0 ± 0.6 | 20.0 ± 0.83 | 22.0 ± 0.43 |
Heart wt., g | 0.17 ± 0.03 | 0.18 ± 0.01 | 0.14 ± 0.013 | 0.14 ± 0.013 |
Heart wt./body wt. ratio | 0.76 ± 0.04 | 0.74 ± 0.04 | 0.79 ± 0.03 | 0.70 ± 0.023 |
Left kidney wt., g | 0.15 ± 0.02 | 0.17 ± 0.01 | 0.13 ± 0.01 | 0.14 ± 0.063 |
Left kidney wt./body wt. ratio | 0.68 ± 0.03 | 0.70 ± 0.01 | 0.77 ± 0.044 | 0.72 ± 0.04 |
Blood volume, ml | 0.54 ± 0.04 | 0.56 ± 0.05 | 0.53 ± 0.03 | 0.59 ± 0.041,3 |
Hematocrit, % | 54 ± 0.7 | 50 ± 1.31 | 50 ± 1.43 | 49 ± 1 |
Fluid intake, ml/24 h | 4.6 ± 0.3 | 5.7 ± 0.62 | 4.9 ± 0.5 | 4.6 ± 0.24 |
Urine volume, ml/24 h | 2.3 ± 0.2 | 1.9 ± 0.2 | 2.0 ± 0.2 | 1.5 ± 0.23 |
Urine Na+ conc., mmol/l | 194 ± 15 | 244 ± 241 | 173 ± 21 | 236 ± 452 |
Urine K+ conc., mmol/l | 262 ± 28 | 285 ± 25 | 273 ± 25 | 385 ± 752,4 |
Urine Cl− conc., mmol/l | 298 ± 18 | 294 ± 44 | 237 ± 26 | 319 ± 872 |
P<0.05 or
P<0.01 vs. male or female WT mice.
P<0.05 or
P<0.01 vs. male WT or PT-Agtr1a−/− mice, respectively.